C12N 2770/22034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/22034 (Use of virus or viral component as vaccine) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 4
- Assignees
- 1
- Inventors
- 5
- Latest grant
- 13 Nov 2007
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
By publication year.
Recent patents
- Protein and peptide expression for passive immunity8 Jun 2006US 2006/0120999 A1
- Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies17 Jul 2003US 2003/0133947 A1Merial Limited
- Avian polynucleotide vaccine formula3 Jul 2003US 2003/0124145 A1
- Avian polynucleotide vaccine formula28 Mar 2002US 2002/0037292 A1Merial Limited
Most cited
By later US patents